| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2056* | 2021 |
| Cryptococcal meningitis T Bicanic, TS Harrison British medical bulletin 72 (1), 99-118, 2004 | 645 | 2004 |
| Cryptococcus: from environmental saprophyte to global pathogen RC May, NRH Stone, DL Wiesner, T Bicanic, K Nielsen Nature Reviews Microbiology 14 (2), 106-117, 2016 | 548 | 2016 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 492* | 2021 |
| Tackling the emerging threat of antifungal resistance to human health MC Fisher, A Alastruey-Izquierdo, J Berman, T Bicanic, EM Bignell, ... Nature reviews microbiology 20 (9), 557-571, 2022 | 475 | 2022 |
| Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions NRH Stone, T Bicanic, R Salim, W Hope Drugs 76, 485-500, 2016 | 465 | 2016 |
| Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes JN Jarvis, T Bicanic, A Loyse, D Namarika, A Jackson, JC Nussbaum, ... Clinical infectious diseases 58 (5), 736-745, 2014 | 393 | 2014 |
| Antifungal combinations for treatment of cryptococcal meningitis in Africa SF Molloy, C Kanyama, RS Heyderman, A Loyse, C Kouanfack, ... New England Journal of Medicine 378 (11), 1004-1017, 2018 | 381 | 2018 |
| Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or … T Bicanic, G Meintjes, R Wood, M Hayes, K Rebe, LG Bekker, T Harrison Clinical infectious diseases 45 (1), 76-80, 2007 | 338 | 2007 |
| Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial JN Jarvis, G Meintjes, K Rebe, GN Williams, T Bicanic, A Williams, ... Aids 26 (9), 1105-1113, 2012 | 305 | 2012 |
| Cryptococcosis diagnosis and treatment: What do we know now JR Perfect, T Bicanic Fungal Genetics and Biology 78, 49-54, 2015 | 297 | 2015 |
| High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial T Bicanic, R Wood, G Meintjes, K Rebe, A Brouwer, A Loyse, LG Bekker, ... Clinical infectious diseases 47 (1), 123-130, 2008 | 288 | 2008 |
| The case for adopting the “species complex” nomenclature for the etiologic agents of cryptococcosis KJ Kwon-Chung, JE Bennett, BL Wickes, W Meyer, CA Cuomo, ... MSphere 2 (1), 10.1128/msphere. 00357-16, 2017 | 282 | 2017 |
| Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution T Bicanic, T Harrison, A Niepieklo, N Dyakopu, G Meintjes Clinical Infectious Diseases 43 (8), 1069-1070, 2006 | 281 | 2006 |
| Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients T Bicanic, C Muzoora, AE Brouwer, G Meintjes, N Longley, K Taseera, ... Clinical infectious diseases 49 (5), 702-709, 2009 | 244 | 2009 |
| Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study T Bicanic, G Meintjes, K Rebe, A Williams, A Loyse, R Wood, M Hayes, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (2), 130-134, 2009 | 237 | 2009 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 236 | 2022 |
| Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures T Bicanic, AE Brouwer, G Meintjes, K Rebe, D Limmathurotsakul, ... Aids 23 (6), 701-706, 2009 | 231 | 2009 |
| Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries A Loyse, H Thangaraj, P Easterbrook, N Ford, M Roy, T Chiller, ... The Lancet infectious diseases 13 (7), 629-637, 2013 | 197 | 2013 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ... Cell 185 (5), 916-938. e58, 2022 | 175 | 2022 |
